162 related articles for article (PubMed ID: 30706176)
21. Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts.
Li D; Li S; Xue AZ; Smith Callahan LA; Liu Y
Medicine (Baltimore); 2020 Mar; 99(12):e18815. PubMed ID: 32195924
[TBL] [Abstract][Full Text] [Related]
22. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.
Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T
Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008
[TBL] [Abstract][Full Text] [Related]
23. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
24. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
[TBL] [Abstract][Full Text] [Related]
25. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
26. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
27. Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma.
Shankavaram UT; Bredel M; Burgan WE; Carter D; Tofilon P; Camphausen K
J Cell Mol Med; 2012 Mar; 16(3):545-54. PubMed ID: 21595825
[TBL] [Abstract][Full Text] [Related]
28. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai Molecular Diagnosis Network for CNS Tumors.
Sasaki T; Fukai J; Kodama Y; Hirose T; Okita Y; Moriuchi S; Nonaka M; Tsuyuguchi N; Terakawa Y; Uda T; Tomogane Y; Kinoshita M; Nishida N; Izumoto S; Nakajima Y; Arita H; Ishibashi K; Shofuda T; Kanematsu D; Yoshioka E; Mano M; Fujita K; Uematsu Y; Nakao N; Mori K; Kanemura Y
J Neurooncol; 2018 Nov; 140(2):329-339. PubMed ID: 30076584
[TBL] [Abstract][Full Text] [Related]
30. A network model of a cooperative genetic landscape in brain tumors.
Bredel M; Scholtens DM; Harsh GR; Bredel C; Chandler JP; Renfrow JJ; Yadav AK; Vogel H; Scheck AC; Tibshirani R; Sikic BI
JAMA; 2009 Jul; 302(3):261-75. PubMed ID: 19602686
[TBL] [Abstract][Full Text] [Related]
31. Novel age-associated DNA methylation changes and epigenetic age acceleration in middle-aged African Americans and whites.
Tajuddin SM; Hernandez DG; Chen BH; Noren Hooten N; Mode NA; Nalls MA; Singleton AB; Ejiogu N; Chitrala KN; Zonderman AB; Evans MK
Clin Epigenetics; 2019 Aug; 11(1):119. PubMed ID: 31426852
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma.
Pan YB; Zhang CH; Wang SQ; Ai PH; Chen K; Zhu L; Sun ZL; Feng DF
J Neurooncol; 2018 Apr; 137(2):395-407. PubMed ID: 29294230
[TBL] [Abstract][Full Text] [Related]
33. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
34. Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Zhang Y; Gao G
J Exp Clin Cancer Res; 2012 May; 31(1):44. PubMed ID: 22578365
[TBL] [Abstract][Full Text] [Related]
35. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
[TBL] [Abstract][Full Text] [Related]
36. Race-associated biological differences among Luminal A breast tumors.
D'Arcy M; Fleming J; Robinson WR; Kirk EL; Perou CM; Troester MA
Breast Cancer Res Treat; 2015 Jul; 152(2):437-48. PubMed ID: 26109344
[TBL] [Abstract][Full Text] [Related]
37. Survival and low-grade glioma: the emergence of genetic information.
Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
[TBL] [Abstract][Full Text] [Related]
38. The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
Bady P; Kurscheid S; Delorenzi M; Gorlia T; van den Bent MJ; Hoang-Xuan K; Vauléon É; Gijtenbeek A; Enting R; Thiessen B; Chinot O; Dhermain F; Brandes AA; Reijneveld JC; Marosi C; Taphoorn MJB; Wick W; von Deimling A; French P; Stupp R; Baumert BG; Hegi ME
Acta Neuropathol; 2018 Apr; 135(4):601-615. PubMed ID: 29368212
[TBL] [Abstract][Full Text] [Related]
39. Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.
Ostrom QT; Egan KM; Nabors LB; Gerke T; Thompson RC; Olson JJ; LaRocca R; Chowdhary S; Eckel-Passow JE; Armstrong G; Wiencke JK; Bernstein JL; Claus EB; Il'yasova D; Johansen C; Lachance DH; Lai RK; Merrell RT; Olson SH; Sadetzki S; Schildkraut JM; Shete S; Houlston RS; Jenkins RB; Wrensch MR; Melin B; Amos CI; Huse JT; Barnholtz-Sloan JS; Bondy ML
Int J Cancer; 2020 Feb; 146(3):739-748. PubMed ID: 30963577
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
